Real-time fMRI Neurofeedback for Mild/Moderate Depression

NCT ID: NCT05025904

Last Updated: 2021-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-06-06

Study Completion Date

2019-04-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to compare the effects of the self-regulation (neurofeedback) of the fMRI signal of the prefrontal cortex in depression to ones of more conventional non-pharmacological treatment, primarily, psychotherapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study was devoted to the neural, clinical, and psychological effects of the rt-fMRI neurofeedback for mild/moderate depression. Recruited unmedicated patients suffering from depression were assigned either to the fMRI neurofeedback (8 sessions of the left prefrontal cortex activity regulation) or to the active control group, i.e., a double dosage of cognitive-behavioral treatment or EEG neurofeedback (preliminary aborted). Depression symptoms were measured at baseline, at mid-treatment, and at post-treatment points. Some inventories of depression and related traits were also given. In the rt-fMRI group, self-regulation learning was also estimated by means of the fMRI signal change.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Mild Depression Moderate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Participants were assigned to one of 3 groups: real-time fMRI neurofeedback (rt-fMRI NFB), EEG neurofeedback (aborted), and cognitive behavioral therapy (CBT).
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Real-time fMRI neurofeedback (rt-fMRI NFB)

The duration of a session was approximately a half-hour. The course duration was 8 sessions. The preferred frequency was once a week, however, the schedule was flexibly adjusted for patients' convenience.

Group Type EXPERIMENTAL

Real-time fMRI neurofeedback (rt-fMRI NFB)

Intervention Type BEHAVIORAL

Real-time fMRI neurofeedback targeting control of the left medial prefrontal cortex. Participants continuously received visual feedback on the level of activity within the 2D region of interest corrected to the whole-slice brain volume activity. Up- and downregulation blocks were switched for better control.

Сognitive behavioral therapy (CBT)

The duration of a session was approximately an hour/hour and a half. The course duration was 8 individual and 8 group sessions and included home assignments. The preferred frequency was twice a week, however, the schedule was flexibly adjusted for patients' convenience and for improving benefits of the treatment.

Group Type ACTIVE_COMPARATOR

Сognitive behavioral therapy (CBT)

Intervention Type BEHAVIORAL

A combination of individual and small-group cognitive behavioral therapy by an experienced medical psychologist and a psychiatrist.

EEG neurofeedback (EEG NFB)

The duration of a session was approximately a half-hour. The course duration was 16 sessions. The preferred frequency was twice a week, however, the schedule was flexibly adjusted for patients' convenience.

Group was preliminarily aborted for lack of time and participants in order to assign more patients to the abovementioned arms.

Group Type ACTIVE_COMPARATOR

EEG neurofeedback (EEG NFB)

Intervention Type BEHAVIORAL

EEG neurofeedback targeting frontal alpha asymmetry index. Participants continuously received visual feedback on their frontal alpha asymmetry index. Up-regulation condition only was utilized.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Real-time fMRI neurofeedback (rt-fMRI NFB)

Real-time fMRI neurofeedback targeting control of the left medial prefrontal cortex. Participants continuously received visual feedback on the level of activity within the 2D region of interest corrected to the whole-slice brain volume activity. Up- and downregulation blocks were switched for better control.

Intervention Type BEHAVIORAL

Сognitive behavioral therapy (CBT)

A combination of individual and small-group cognitive behavioral therapy by an experienced medical psychologist and a psychiatrist.

Intervention Type BEHAVIORAL

EEG neurofeedback (EEG NFB)

EEG neurofeedback targeting frontal alpha asymmetry index. Participants continuously received visual feedback on their frontal alpha asymmetry index. Up-regulation condition only was utilized.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A diagnosis of unipolar depressive disorder on ICD-10 (F32, F33, F34.1)
* Sufficient self-regulation ability (verified with 3 sessions of ALAY EEG neurofeedback)

Exclusion Criteria

* Serious somatic, mental, or substance abuse problem other than depression
* Depression secondary to other mental or somatic conditions
* Psychotic features in depression or comorbid psychotic disorder
* Serious suicide risk
* Seasonal depression
* Receiving or planning to receive psychotropic medications
* Receiving cardiovascular medications
* General MRI exclusions
* Current pregnancy
* IQ\<70 (established with Raven's progressive matrices)
* Previous experience with neurofeedback
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federal Research Center of Fundamental and Translational Medicine, Russian Federation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark B. Shtark, Ph.D.

Role: STUDY_DIRECTOR

FRC FTM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Federal Reserch Center of Fundamental and Translational Medicine

Novosibirsk, , Russia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Russia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16-15-00183

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Neurofeedback to Treat Depression
NCT05169346 COMPLETED NA
Neurofeedback to Treat Depression - 2
NCT07159061 RECRUITING NA